CVVHIGH SIGNALOPERATIONAL10-K

CVV is executing a major restructuring by divesting its SDC division to Atlas Copco for $16.9 million while closing its MesoScribe operations, fundamentally reshaping the company into a single-segment CVD Equipment business.

This represents a strategic pivot that will concentrate CVV's operations around its core CVD Equipment segment while generating significant cash proceeds from the SDC divestiture. The elimination of two business segments and focus on equipment manufacturing should simplify operations and potentially improve margins, though it also reduces diversification and revenue base going forward.

Comparing 2026-03-30 vs 2025-03-19View on EDGAR →
FINANCIAL ANALYSIS

CVV delivered substantially higher revenue performance while meaningfully reducing operating losses, indicating improved operational efficiency during the transition year. The company maintained a strong balance sheet with significantly reduced liabilities and adequate cash reserves, though cash levels declined moderately. The financial profile suggests successful execution of the restructuring strategy with improved operational metrics supporting the strategic refocusing initiative.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+96.3%
$21.0M$41.1M

Strong top-line growth of 96.3% — accelerating demand or successful expansion into new markets.

Total Liabilities
Balance Sheet
-55.9%
$6.3M$2.8M

Liabilities reduced 55.9% — deleveraging improves balance sheet strength and financial flexibility.

Capital Expenditure
Cash Flow
-54.7%
$106K$48K

Capex reduced 54.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
-54.6%
$6.1M$2.8M

Current liabilities reduced — improved short-term financial position and working capital health.

Cash & Equivalents
Balance Sheet
-30.7%
$12.6M$8.7M

Cash declined 30.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Inventory
Balance Sheet
-25.9%
$2.1M$1.6M

Inventory reduced 25.9% — lean inventory management or demand outpacing supply.

Total Debt
Balance Sheet
-23.2%
$349K$268K

Debt reduced 23.2% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Income
P&L
+20.9%
-$2.4M-$1.9M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Net Income
P&L
+16.5%
-$1.9M-$1.6M

Net income grew 16.5% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
-15.5%
$20.0M$16.9M

Current assets declined 15.5% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-03-19
ADDED
As of March 27, 2026, 6,937,338 shares of the Registrant s common stock, $ 0.01 par value were outstanding.
We are headquartered in Central Islip, New York with our Stainless Design Concepts ( SDC ) division located in Saugerties, New York.
We currently conduct our business through two reportable segments: i) CVD Equipment that designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and ii) SDC that designs and manufactures ultra-high purity gas and chemical delivery control systems.
Our MesoScribe reportable segment ceased operations in 2024 and had provided products related to advanced materials and coatings.
Developments On March 23, 2026, we entered into a definitive agreement under which our SDC business division will be sold to a subsidiary of the Atlas Copco Group.
+7 more — sign up free →
REMOVED
We are headquartered in Central Islip, New York with our SDC division located in Saugerties, New York.
We conduct our business through three reportable segments: i) CVD Equipment that designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; ii) SDC that designs and manufactures ultra-high purity gas and chemical delivery control systems; and iii) MesoScribe that provided products related to advanced materials and coatings.
Developments On August 8, 2023, we entered into an agreement with a third party to sell certain assets and license certain propriety information of our MesoScribe subsidiary.
We fulfilled remaining orders for MesoScribe products during 2024 and sold certain equipment resulting in the recognition of a gain on sale of equipment in 2024.
On May 26, 2023, we sold our Tantaline subsidiary located in Nordborg, Denmark in exchange for a nominal amount at closing and an earn-out provision based on any net income that Tantaline may earn during the five-year period ending December 31, 2027.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NOWHIGHServiceNow has fundamentally repositioned itself as an AI-first platform company...
2026-01-29
TSLAHIGHTesla has fundamentally repositioned itself from an electric vehicle company to ...
2026-01-29
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →